Tag: refractory advanced renal cell carcinoma

Home / refractory advanced renal cell carcinoma

Categories

Tivozanib has been approved by the FDA for the treatment of relapsed or refractory advanced renal cell carcinoma

August 2021: Tivozanib (Fotivda, AVEO Pharmaceuticals, Inc.), a kinase inhibitor, has been approved by the FDA for adult patients with relapsed or refractory advanced renal cell carcinoma (RCC) after ...
refractory-advanced-renal-cell-carcinoma

Scan the code